Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-016523
Filing Date
2025-05-13
Accepted
2025-05-13 17:15:59
Documents
83
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zvra20250331_10q.htm   iXBRL 10-Q 1233086
2 EXHIBIT 2.1 ex_799842.htm EX-2.1 183726
3 EXHIBIT 10.1 ex_799498.htm EX-10.1 13617
4 EXHIBIT 31.1 ex_762495.htm EX-31.1 13725
5 EXHIBIT 31.2 ex_762496.htm EX-31.2 13823
6 EXHIBIT 32.1 ex_762497.htm EX-32.1 6965
7 EXHIBIT 32.2 ex_762498.htm EX-32.2 7235
  Complete submission text file 0001437749-25-016523.txt   7228278

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA zvra-20250331.xsd EX-101.SCH 70854
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zvra-20250331_cal.xml EX-101.CAL 53769
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20250331_def.xml EX-101.DEF 441582
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20250331_lab.xml EX-101.LAB 392493
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20250331_pre.xml EX-101.PRE 473158
86 EXTRACTED XBRL INSTANCE DOCUMENT zvra20250331_10q_htm.xml XML 1030386
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 25941371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)